Literature DB >> 2974048

Inhibition of the anticoagulant activity of protein S by prothrombin.

C A Mitchell1, S M Jane, H H Salem.   

Abstract

Protein S is a vitamin K-dependent protein cofactor to the anticoagulant, activated protein C (APC). This study examines the inhibition of human protein S anticoagulant activity by prothrombin. In the absence of protein S, the anticoagulant activity of APC measured in a Factor Xa recalcification time, was comparable using normal or plasma adsorbed with Al(OH)3. Protein S was an effective cofactor to APC in Al(OH)3-adsorbed plasma, but was significantly less active in normal plasma. Analysis of the difference in the two plasmas revealed that normal plasma contained an inhibitor to the anticoagulant activity of protein S that was removed by Al(OH)3 adsorption. Purification of this inhibitory activity demonstrated that it was mediated by the vitamin K-dependent protein, prothrombin. Prothrombin purified by conventional techniques caused immediate, dose-dependent inhibition of the cofactor activity of protein S in the presence of phospholipids or platelets, but had no effect on the anticoagulant activity of APC. The inhibition was demonstrable using a Factor Xa recalcification time, and studies of the rates of inactivation of purified Factor Va. Increasing concentrations of protein S overcame the inhibition by prothrombin and kinetic analysis of the interaction demonstrated that prothrombin acted as a competitive inhibitor to protein S. Immunoabsorption of prothrombin from plasma using immobilized antiprothrombin antibodies was associated with the complete removal of the protein S inhibitory activity. We conclude that the anticoagulant activity of protein S is modulated by prothrombin and that this may represent another regulatory mechanism of the natural anticoagulant system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974048      PMCID: PMC442798          DOI: 10.1172/JCI113836

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X.

Authors:  J P Miletich; G J Broze; P W Majerus
Journal:  Anal Biochem       Date:  1980-07-01       Impact factor: 3.365

2.  The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

Authors:  F J Walker; P W Sexton; C T Esmon
Journal:  Biochim Biophys Acta       Date:  1979-12-07

3.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

4.  Control of thrombin mediated cleavage of protein S.

Authors:  C A Mitchell; L Hau; H H Salem
Journal:  Thromb Haemost       Date:  1986-10-21       Impact factor: 5.249

5.  Purification and characterization of human coagulation factor V.

Authors:  W H Kane; P W Majerus
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

6.  Properties of the factor Xa binding site on human platelets.

Authors:  J P Miletich; C M Jackson; P W Majerus
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

7.  Preparation and properties of bovine factor VIII (antihemophilic factor).

Authors:  G A Vehar; E W Davie
Journal:  Biochemistry       Date:  1980-02-05       Impact factor: 3.162

8.  Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.

Authors:  J P Miletich; D W Majerus; P W Majerus
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

9.  Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

Authors:  W Kisiel
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

10.  Regulation of activated protein C by a new protein. A possible function for bovine protein S.

Authors:  F J Walker
Journal:  J Biol Chem       Date:  1980-06-25       Impact factor: 5.157

View more
  2 in total

1.  Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.

Authors:  Thomas J Cramer; John H Griffin; Andrew J Gale
Journal:  Pathophysiol Haemost Thromb       Date:  2010-05-22

2.  Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.

Authors:  Subramanian Yegneswaran; Phuong M Nguyen; Andrew J Gale; John H Griffin
Journal:  Thromb Haemost       Date:  2009-01       Impact factor: 5.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.